Related Experiment Videos
Ornithine decarboxylase activity in tissues of prolactin-treated rats
Biochemical and Biophysical Research Communications
|March 3, 1975
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Function and origin of multiple ionic forms of hormone-induced ornithine decarboxylase.
Archives of biochemistry and biophysics·1993
Tetanus. A threat to elderly patients.
Postgraduate medicine·1992
Changes in antizyme-ornithine decarboxylase complexes in tissues of hormone-treated rats.
Archives of biochemistry and biophysics·1989
Multiple ionic forms of ornithine decarboxylase differ in degree of phosphorylation.
Biochemical and biophysical research communications·1988
An inhibitor of ornithine decarboxylase in lactogen-deprived Nb2 node rat lymphoma cells.
Biochimica et biophysica acta·1986
A dynamic homodimer structure of the response regulator FixJ from Bradyrhizobium japonicum in its phosphorylated state in aqueous solution.
Biochemical and biophysical research communications·2026
Cipepofol inhibits the proliferation, migration and invasion of breast cancer cells by inducing ferroptosis.
Biochemical and biophysical research communications·2026
Melatonin-loaded nanoparticles reduce cisplatin-induced oxidative stress and lymphopenia: An experimental study in rats.
Biochemical and biophysical research communications·2026
CCL2/CCR2 axis suggests a role in bridging obesity-related adipose inflammation to Sertoli cell injury in asthenozoospermia: Integrated multi-omics, machine learning and in vitro validation.
Biochemical and biophysical research communications·2026
Effects and mechanisms of Stauntonia brachyanthera Hand.-Mazz against Alzheimer's disease through network pharmacology and experimental validation.
Biochemical and biophysical research communications·2026
SIRT6 restrains hyperactivated Nrf2 to enhance cisplatin response in lung cancer models.
Biochemical and biophysical research communications·2026
Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's Disease.
Drug design, development and therapy·2026
PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.
Molecular therapy. Nucleic acids·2026
miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.
Molecular therapy. Nucleic acids·2026